Table 2.
Group | Body weight (g) | Relative liver weight (%) | Relative kidney weight (%) |
---|---|---|---|
C | 386.5 ± 22.1 | 2.28 ± 0.11 | 0.62 ± 0.05 |
M | 326.6 ± 20.7▲▲ | 2.23 ± 0.11 | 0.74 ± 0.05▲▲ |
A | 343.8 ± 36.0▲▲ | 2.38 ± 0.05 | 0.72 ± 0.07▲▲ |
AR-L | 351.9 ± 32.1▲ | 2.33 ± 0.15 | 0.71 ± 0.07▲▲ |
AR-H | 338.5 ± 19.8▲▲ | 2.31 ± 0.14 | 0.68 ± 0.06 |
RSG-L | 329.8 ± 35.1▲▲ | 2.32 ± 0.15 | 0.77 ± 0.10▲▲ |
RSG-H | 250.2 ± 28.5▲▲∗∗ | 2.82 ± 0.34▲∗ | 0.75 ± 0.09▲▲ |
C, control; M, model; A, allopurinol; AR-L, low dose of AR; AR-H, high dose of AR; RSG-L, low dose of RSG; RSG-H, high dose of RSG. ▲ and ▲▲ indicate values significantly different from those of the control group at the levels of P < 0.05 and P < 0.01, respectively. ∗ and ∗∗ indicate values significantly different from those of the model group at the levels of P < 0.05 and P < 0.01, respectively.